pentobarbital will reduce the extent or effect of naloxegol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Utilization of naloxegol with potent CYP3A4 inducers is not encouraged pentobarbital will lower the extent or effect of budesonide by impacting hepatic/intestinal